Inventor
HE YALI
US32 patents
⚠️ This page may combine multiple inventors who share the name “HE YALI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV TENNESSEE RES FOUND
15 patentsUS11230531B2Jan 25, 2022
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
UNIV TENNESSEE RES FOUND6 citations86
US11230523B2Jan 25, 2022
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
UNIV TENNESSEE RES FOUND8 citations86
US10654809B2May 19, 2020
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
UNIV TENNESSEE RES FOUND11 citations86
US11273147B2Mar 15, 2022
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
UNIV TENNESSEE RES FOUND7 citations85
US10865184B2Dec 15, 2020
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
UNIV TENNESSEE RES FOUND9 citations84
US10806720B2Oct 20, 2020
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
UNIV TENNESSEE RES FOUND9 citations84
US10806719B2Oct 20, 2020
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
UNIV TENNESSEE RES FOUND7 citations84
US10314797B2Jun 11, 2019
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
UNIV TENNESSEE RES FOUND13 citations84
US11873282B2Jan 16, 2024
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
UNIV TENNESSEE RES FOUND4 citations75
US11648234B2May 16, 2023
Selective androgen receptor degrader (SARD) ligands and methods of use
UNIV TENNESSEE RES FOUND5 citations75
US12215086B2Feb 4, 2025
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
UNIV TENNESSEE RES FOUND0 citations62
US12202815B2Jan 21, 2025
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
UNIV TENNESSEE RES FOUND0 citations62
US12128026B2Oct 29, 2024
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
UNIV TENNESSEE RES FOUND0 citations62
US9493403B2Nov 15, 2016
Treating androgen decline in aging male (ADAM)-associated conditions with SARMs
UNIV TENNESSEE RES FOUND0 citations52
US12329755B2Jun 17, 2025
Bromodomain inhibitors to target therapy-resistant cancer
UNIV TENNESSEE RES FOUND0 citations42
UNIV TENNESSEE RES FOUNDATION
7 patentsUS6998500B2Feb 14, 2006
Selective androgen receptor modulators and methods of use thereof
UNIV TENNESSEE RES FOUNDATION106 citations98
US6995284B2Feb 7, 2006
Synthesis of selective androgen receptor modulators
UNIV TENNESSEE RES FOUNDATION124 citations98
US6838484B2Jan 4, 2005
Formulations comprising selective androgen receptor modulators
UNIV TENNESSEE RES FOUNDATION137 citations98
US7759520B2Jul 20, 2010
Synthesis of selective androgen receptor modulators
UNIV TENNESSEE RES FOUNDATION27 citations92
US7518013B2Apr 14, 2009
Selective androgen receptor modulators
UNIV TENNESSEE RES FOUNDATION28 citations92
US7205437B2Apr 17, 2007
Selective androgen receptor modulators
UNIV TENNESSEE RES FOUNDATION46 citations92
US7919647B2Apr 5, 2011
Selective androgen receptor modulators and methods of use thereof
UNIV TENNESSEE RES FOUNDATION6 citations63
GTX INC
5 patentsUS10441570B2Oct 15, 2019
Selective androgen receptor degrader (SARD) Ligands and methods of use thereof
GTX INC12 citations84
US10035763B2Jul 31, 2018
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
GTX INC15 citations84
US10017471B2Jul 10, 2018
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
GTX INC15 citations84
US9814698B2Nov 14, 2017
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
GTX INC17 citations84
US9409856B2Aug 9, 2016
Estrogen receptor ligands and methods of use thereof
GTX INC1 citations48